Romosozumab is prescribed for:
- Postmenopausal osteoporosis at high fracture risk
- Endocrine bone conditions
- Patients with very high fracture risk
Dual mechanism: increases bone formation AND decreases bone resorption.
Generic Name: Romosozumab-aqqg
Brand Names: Evenity
Romosozumab is a sclerostin inhibitor that both builds bone and reduces bone breakdown for severe osteoporosis.
Romosozumab is prescribed for:
Dual mechanism: increases bone formation AND decreases bone resorption.
Common side effects:
Serious side effects (boxed warning):
Romosozumab is a monoclonal antibody that inhibits sclerostin, a protein that normally inhibits bone formation.
Uniquely both:
Boxed warning for increased cardiovascular risk. Avoid in patients with recent MI or stroke.
For more information, see MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Osteoporosis weakens bones due to age, hormonal changes, poor diet, medications, certain medical conditions, and lifestyle factors, increasing fracture risk even from minor incidents.
A stroke, caused by interrupted brain blood supply from blockage (ischemic) or bleeding (hemorrhagic), is a medical emergency requiring prompt treatment to minimize brain damage.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Romosozumab? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.